Terms: = Leukemia AND STAT5B, STAT5, 6777, ENSG00000173757, P51692 AND Clinical Outcome
6 results:
1. Dual inhibition of STAT3 and stat5 may overcome imatinib resistance in chronic myeloid leukemia.
Yin L; Xu J; Wu W; Niu M; Li Z; Zhu F; Xu K
Hematology; 2023 Dec; 28(1):2224625. PubMed ID: 37345979
[TBL] [Abstract] [Full Text] [Related]
2. Phenotype, Function, and clinical Significance of CD26+ and CD161+Tregs in Splenic Marginal Zone Lymphoma.
Tang X; Yang ZZ; Kim HJ; Anagnostou T; Yu Y; Wu X; Chen J; Krull JE; Wenzl K; Mondello P; Bhardwaj V; Wang J; Novak AJ; Ansell SM
Clin Cancer Res; 2022 Oct; 28(19):4322-4335. PubMed ID: 35686915
[TBL] [Abstract] [Full Text] [Related]
3. leukemia associated mutant Wilms' tumor gene 1 protein promotes expansion of human hematopoietic progenitor cells.
Vidovic K; Ullmark T; Rosberg B; Lennartsson A; Olofsson T; Nilsson B; Gullberg U
Leuk Res; 2013 Oct; 37(10):1341-9. PubMed ID: 23871158
[TBL] [Abstract] [Full Text] [Related]
4. Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression.
Sato T; Tran TH; Peck AR; Girondo MA; Liu C; Goodman CR; Neilson LM; Freydin B; Chervoneva I; Hyslop T; Kovatich AJ; Hooke JA; Shriver CD; Fuchs SY; Rui H
Oncogene; 2014 Apr; 33(17):2215-24. PubMed ID: 23708665
[TBL] [Abstract] [Full Text] [Related]
5. Expression of phosphorylated signal transducer and activator of transcription 5 is associated with an increased risk of death in acute myeloid leukemia.
Brady A; Gibson S; Rybicki L; Hsi E; Saunthararajah Y; Sekeres MA; Tiu R; Copelan E; Kalaycio M; Sobecks R; Bates J; Advani AS
Eur J Haematol; 2012 Oct; 89(4):288-93. PubMed ID: 22725130
[TBL] [Abstract] [Full Text] [Related]
6. Structural and numerical variation of FLT3/ITD in pediatric AML.
Meshinchi S; Stirewalt DL; Alonzo TA; Boggon TJ; Gerbing RB; Rocnik JL; Lange BJ; Gilliland DG; Radich JP
Blood; 2008 May; 111(10):4930-3. PubMed ID: 18305215
[TBL] [Abstract] [Full Text] [Related]
